Drug Shortage Report for APO-VENLAFAXINE XR

Last updated on 2020-09-14 History
Report ID 103926
Drug Identification Number 02331691
Brand name APO-VENLAFAXINE XR
Common or Proper name VENLAFAXINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 75.0MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100 BTL
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-20
Estimated end date 2020-09-18
Actual end date 2020-09-11
Shortage status Resolved
Updated date 2020-09-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-09-14 French Compare
v19 2020-09-14 English Compare
v18 2020-09-09 French Compare
v17 2020-09-09 English Compare
v16 2020-08-28 French Compare
v15 2020-08-28 English Compare
v14 2020-08-14 French Compare
v13 2020-08-14 English Compare
v12 2020-07-30 French Compare
v11 2020-07-30 English Compare
v10 2020-07-10 French Compare
v9 2020-07-10 English Compare
v8 2020-05-27 French Compare
v7 2020-05-27 English Compare
v6 2020-03-30 French Compare
v5 2020-03-30 English Compare
v4 2020-02-06 French Compare
v3 2020-02-06 English Compare
v2 2020-01-22 French Compare
v1 2020-01-22 English Compare